Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$462M |
| 2 |
NVIDIA
NVDA
|
+$385M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Apple
AAPL
|
+$301M |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$381M |
| 2 |
ExxonMobil
XOM
|
+$352M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$223M |
| 4 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$136M |
| 5 |
SoFi Technologies
SOFI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 18.32% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Sensus Healthcare
SRTS
$46.9M
| $2.62M | ﹤0.01% |
378,568
+88,953
| +31% | +$652K |
|
2727
Duluth Holdings
DLTH
$152M
| $2.61M | ﹤0.01% |
843,672
+58,991
| +8% | +$214K |
|
|
ONL
2728
Orion Office REIT
ONL
$151M
| $2.59M | ﹤0.01% |
697,878
-14,516
| -2% | -$57.1K |
|
2729
NN Inc
NNBR
$237M
| $2.56M | ﹤0.01% |
783,033
+106,518
| +16% | +$407K |
|
2730
Bloom Energy
BE
$46.6B
| $2.54M | ﹤0.01% |
+114,352
| New | +$2M |
|
2731
Sana Biotechnology
SANA
$882M
| $2.54M | ﹤0.01% |
1,557,496
+478,596
| +44% | +$1.43M |
|
|
ATXS
2732
DELISTED
Astria Therapeutics
ATXS
| $2.49M | ﹤0.01% |
278,072
-2,241
| -0.8% | -$23.8K |
|
|
SSBK
2733
DELISTED
Southern States Bancshares
SSBK
| $2.47M | ﹤0.01% |
74,176
+13,925
| +23% | +$469K |
|
|
VERV
2734
DELISTED
Verve Therapeutics
VERV
| $2.46M | ﹤0.01% |
437,089
+5,320
| +1% | +$30K |
|
2735
Viemed Healthcare
VMD
$447M
| $2.46M | ﹤0.01% |
306,522
| – | – |
|
2736
Keros Therapeutics
KROS
$197M
| $2.46M | ﹤0.01% |
155,163
+2,727
| +2% | +$142K |
|
2737
MeiraGTx Holdings
MGTX
$1.08B
| $2.43M | ﹤0.01% |
398,813
-51,081
| -11% | -$299K |
|
2738
Astera Labs
ALAB
$42.8B
| $2.42M | ﹤0.01% |
18,250
+768
| +4% | +$72.1K |
|
2739
RGC Resources
RGCO
$233M
| $2.42M | ﹤0.01% |
120,400
+3,684
| +3% | +$76.4K |
|
2740
Byrna Technologies
BYRN
$98.3M
| $2.41M | ﹤0.01% |
83,801
+45,730
| +120% | +$896K |
|
2741
ENI
E
$78.1B
| $2.41M | ﹤0.01% |
88,054
+11,824
| +16% | +$346K |
|
2742
Takeda Pharmaceutical
TAK
$56.7B
| $2.41M | ﹤0.01% |
181,929
+68,200
| +60% | +$937K |
|
2743
Rubrik
RBRK
$14.8B
| $2.4M | ﹤0.01% |
36,741
+1,363
| +4% | +$67.3K |
|
2744
Check Point Software Technologies
CHKP
$14.3B
| $2.37M | ﹤0.01% |
12,712
+103
| +0.8% | +$19.4K |
|
2745
Personalis
PSNL
$1.25B
| $2.37M | ﹤0.01% |
410,083
+242,141
| +144% | +$1.12M |
|
|
BHR
2746
Braemar Hotels & Resorts
BHR
$163M
| $2.35M | ﹤0.01% |
784,311
-27,576
| -3% | -$89.3K |
|
2747
Dyne Therapeutics
DYN
$4.15B
| $2.35M | ﹤0.01% |
99,578
-66,569
| -40% | -$1.97M |
|
|
DGICB
2748
Donegal Group Class B
DGICB
$811M
| $2.34M | ﹤0.01% |
165,787
| – | – |
|
2749
GrowGeneration
GRWG
$84.7M
| $2.33M | ﹤0.01% |
1,381,141
-50,561
| -4% | -$96.7K |
|
2750
MacroGenics
MGNX
$233M
| $2.33M | ﹤0.01% |
717,288
-165,372
| -19% | -$596K |
|
Similar funds
Dimensional Fund Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Dimensional Fund Advisors held 3,410 positions worth $416B, up 0.99% from $412B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.9%. Dimensional Fund Advisors opened 61 new positions and exited 71, leaving the 3,410-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2024 buy was Everus Construction Group: 1,833,827 shares worth $121M.
- Dimensional Fund Advisors added most to Merck in Q4 2024, an estimated $462M increase.
- Dimensional Fund Advisors's biggest Q4 2024 reduction was ExxonMobil, cutting an estimated $352M.
- Dimensional Fund Advisors fully exited Southwestern Energy Company in Q4 2024, selling an estimated $381M.
- Dimensional Fund Advisors's ten largest holdings make up 16% of its $416B portfolio in Q4 2024.
- Dimensional Fund Advisors opened 61 new positions and closed 71 in Q4 2024.
- Dimensional Fund Advisors's portfolio value rose 0.99% quarter-over-quarter to $416B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.